SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Stocks to Watch

 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext  
To: Al Collard who started this subject1/3/2001 5:19:47 AM
From: Al Collard  Read Replies (1) of 592
 
Stocks to watch for Wed

AXA-t...this manufacturer of computer, Internet and telecommunications products, currently owns a 25% stake in Nixxo Technologies which is being acquired by Harmony Trading Corp. This represents an equity value of $42 million or $1.32 per share to AXA. With an anticipated closing date sometime this month for the above acquisition this stock should be making headline news shortly, so keep it on your radar screens.

BVG-t...this beaten down puppy is building a network of managed data storage facilities. It has a unique relationship with IBM which includes financing for it's build-out. What makes this stock worthy of keeping a close eye on is it's 12.6% ownership of Wavve especially after yesterday's big run-up in WV's share price.

CZ-v...is a provider of software and internet solutions to the auto industry. Last year this company made 10 acquisitions and entered into several strategic partnerships and just reported a 222% increase in sales last quarter. With expected consolidation and reduction of expenses from their acquisitions this company could indeed be one to watch for 2001.

LAN-t...is a manufacturer of optical wireless products. With numerous distribution agreements in place and the expected release of new products shortly this is a company to keep an eye on as it's share price will be news driven.

SYB-t...this biotech company has been granted a "Fast Track" designation by the FDA and is currently in Phase III clinical trials for it's lead product SYNSORB Cd (R). The company also owns a 39% stake in ONC-t a biotech company developing a potential cancer theraputic. A stock to watch in the hot biotech sector.

this is a watchlist only...please do your own DD

regards,
atial
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext